Detection of 2-hydroxyglutarate in IDH-mutated glioma patients by in vivo spectral-editing and 2D correlation magnetic resonance spectroscopy.

Detection of 2-hydroxyglutarate in IDH-mutated glioma patients by in vivo spectral-editing and 2D correlation magnetic resonance spectroscopy.
复制标题

DOI:
10.1126/scitranslmed.3002693
复制
发表时间:
2012-01-11
影响因子:
17.1
通讯作者:
Sorensen AG
Sorensen AG
中科院分区:
医学1区
文献类型:
--
作者:
Andronesi OC;Kim GS;Gerstner E;Batchelor T;Tzika AA;Fantin VR;Vander Heiden MG;Sorensen AG

文献摘要

参考文献

被引文献

相似文献

异柠檬酸脱氢酶1 (IDH1)中精氨酸132 (R132)的突变存在于高达86%的II级和III级胶质瘤和继发性胶质母细胞瘤中。IDH1的R132突变导致代谢物2-羟基戊二酸(2HG)的过量产生,这可以用作该神经胶质瘤亚群的生物标志物。在这里,我们使用优化的光谱编辑和二维(2D)相关磁共振波谱(MRS)方法,在IDH1突变的胶质瘤患者中明确地检测2HG。相比之下,由于2HG和化学上相似的脑代谢物(如谷氨酸和谷氨酰胺)的光谱重叠,传统的1D MR光谱拟合可能会产生假阳性读数。通过对另一组胶质瘤活检样本进行二维高分辨率魔角旋转MRS,也发现了2HG。通过体内或离体磁共振检测2HG,可以对临床上重要的人类胶质瘤亚群进行详细的分子表征。这对诊断和监测针对IDH突变的治疗具有重要意义。
Mutations of arginine 132 (R132) in the enzyme isocitrate dehydrogenase-1 (IDH1) are present in up to 86% of grade II and III gliomas and secondary glioblastoma. R132 mutations in IDH1 result in excess production of the metabolite 2-hydroxyglutarate (2HG), which could be used as a biomarker for this subset of gliomas. Here, we use optimized spectral-editing and two-dimensional (2D) correlation magnetic resonance spectroscopy (MRS) methods to unambiguously detect 2HG non-invasively in glioma patients with IDH1 mutations. By comparison, fitting of conventional 1D MR spectra can provide false-positive readouts owing to spectral overlap of 2HG and chemically similar brain metabolites, such as glutamate and glutamine. 2HG has been found also by 2D high-resolution magic angle spinning MRS performed ex vivo on a separate set of glioma biopsy samples. 2HG detection by in vivo or ex vivo MRS enabled detailed molecular characterization of a clinically important subset of human gliomas. This has implications for diagnosis as well as monitoring of treatments targeting IDH mutations.
DOI: 10.1038/nature08617
发表时间: 2009-12-10
期刊: Nature
影响因子: 64.8
作者:
通讯作者: --
DOI: 10.1006/jmre.1997.1215
发表时间: 1997-09-01
影响因子: 2.2
作者:
Lin, YY;Hodgkinson, P;Pines, A
通讯作者: Pines, A
DOI: 10.1002/nbm.1688
发表时间: 2011-12-01
期刊: NMR IN BIOMEDICINE
影响因子: 2.9
作者:
Near, Jamie;Simpson, Robin;Jezzard, Peter
通讯作者: Jezzard, Peter
DOI: 10.1002/nbm.888
发表时间: 2004-06-01
期刊: NMR IN BIOMEDICINE
影响因子: 2.9
作者:
Martínez-Bisbal, MC;Martí-Bonmatí, L;Celda, B
通讯作者: Celda, B
DOI: 10.1126/science.1164382
发表时间: 2008-09-26
期刊: Science (New York, N.Y.)
影响因子: --
作者:
Parsons DW;Jones S;Zhang X;Lin JC;Leary RJ;Angenendt P;Mankoo P;Carter H;Siu IM;Gallia GL;Olivi A;McLendon R;Rasheed BA;Keir S;Nikolskaya T;Nikolsky Y;Busam DA;Tekleab H;Diaz LA Jr;Hartigan J;Smith DR;Strausberg RL;Marie SK;Shinjo SM;Yan H;Riggins GJ;Bigner DD;Karchin R;Papadopoulos N;Parmigiani G;Vogelstein B;Velculescu VE;Kinzler KW
通讯作者: Kinzler KW